Publications

Journal Article Epublish 95 citations
Electronic publication date
October 31, 2017

View on Pubmed.gov 29081665 | View on doi.org 10.2147/OTT.S14...

Clinical significance of , epithelial-mesenchymal transition, and cancer stem cell markers in stage III/IV colorectal cancer patients.

Search for publications in this journal Onco Targets Ther

  • Xuebing Yan

    Search for this expert
    1
  • Liguo Liu

    Search for this expert
    2
  • Hao Li

    Search for this expert
    1
  • Huanlong Qin

    Search for this expert
    1
  • Zhenliang Sun

    Search for this expert
    3

Abstract

Colorectal cancer (CRC) is a common digestive malignancy and emerging studies have closely linked its initiation and development with gut microbiota changes. () has been recently identified as a pathogenic bacteria for CRC; however, its prognostic significance for patients is poorly investigated and is less for patients within late stage. Therefore, in this study, we made efforts to analyze its level and prognostic significance in a retrospective cohort of 280 stage III/IV CRC patients. We found that the level was abnormally high in tumor tissues and correlated with tumor invasion, lymph node metastasis status, and distant metastasis. We also identified it as an independent adverse prognostic factor for cancer-specific survival (CSS) and disease-free survival (DFS). The following subgroup analysis indicated that level could stratify CSS and DFS in stage IIIB/C and IV patients but failed in stage IIIA patients. In addition, stage III/IV patients with low level were found to benefit more from adjuvant chemotherapy than those with high level, in terms of DFS. Finally, we analyzed the expression and clinical significance of epithelial-to-mesenchymal transition (EMT) markers (E-cadherin and N-cadherin) and cancer stem cell (CSC) markers (Nanog, Oct-4, and Sox-2) in CRC tissues. The results indicated that N-cadherin, Nanog, Oct-4, and Sox-2 were adverse prognostic factors in these patients, while the opposite was true for E-cadherin. More importantly, expression of E-cadherin, N-cadherin, and Nanog was significantly correlated with level in tumor tissues, suggesting the potential involvement of in EMT-CSC cross talk during CRC progression. Taken together, these findings indicate that is a novel predictive biomarker for clinical management in stage III/IV patients, and targeting may be an effective adjuvant approach for preventing CRC metastasis and chemotherapy resistance.

References

Am J Cancer Res. 2016 Oct 01;6(10 ):2323-2333

ESMO Open. 2016 Sep 16;1(5):e000088

PLoS One. 2015 Mar 25;10 (3):e0120050

CA Cancer J Clin. 2017 May 6;67(3):177-193

Cited by 95 citations (total)

Journal Article Review

Progress in characterizing the linkage between Fusobacterium nucleatum and gastrointestinal cancer.

Electronic publication date December 18, 2019

Search for publications in this journal J Gastroenterol

Yang Liu [...] Hideo Baba et al.

Microbiome research is a rapidly advancing field in human cancers. Fusobacterium nucleatum is an oral bacterium, indigenous to the human...

Journal Article Review

Fusobacterium nucleatum and oral cancer: a critical review.

Electronic publication date February 19, 2022

Search for publications in this journal BMC Cancer

Emily McIlvanna [...] Jacqueline A James et al.

There is a growing level of interest in the potential role inflammation has on the initiation and progression of malignancy....

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

MeSH

Specialties